Get started
Award

GPH-129344

Funded outputs count: 38
Funder award ID: GPH-129344
OpenAlex ID: G5604884852
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups
2026 · Hagai Levi, Qin Wang, et al. · medRxiv
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2024 · Clarke, C.L., Anton-Culver, H., et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2024 · Castelao, J.E., Geisler, J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2024 · Koutros, S., Janni, W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
2024 · Manoukian, S., Ramachandran, D., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis
2023 · Nikos Papadimitriou, Nabila Kazmi, et al. · Cancer Medicine · 3
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
2023 · Pooja Middha, Xiaoliang Wang, et al. · Breast Cancer Research · 13
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
2023 · Stefanie H. Mueller, Alvina G. Lai, et al. · Genome Medicine · 15
PDF
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 28
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2022 · Suzanne C Dixon-Suen, Sarah J Lewis, et al. · British Journal of Sports Medicine · 87
Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study
2022 · Daniela Mariosa, Karl Smith-Byrne, et al. · JNCI Journal of the National Cancer Institute · 28
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
2022 · Xiaoliang Wang, Pooja Middha Kapoor, et al. · Scientific Reports · 6
PDF
Rare germline copy number variants (CNVs) and breast cancer risk
2022 · Joe Dennis, Jonathan P. Tyrer, et al. · Communications Biology · 15
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2021 · Maria Escala-Garcia, Sander Canisius, et al. · Scientific Reports · 5
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2021 · Anna Morra, Maria Escala-Garcia, et al. · Breast Cancer Research · 22
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
2021 · Morra, Anna, Escala-Garcia, Maria, et al. · Apollo (University of Cambridge)
PDF
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
2021 · Hanla A. Park, Sonja Neumeyer, et al. · British Journal of Cancer · 22
PDF
Genome-Wide Interaction Analysis of Menopausal Hormone Therapy Use and Breast Cancer Risk Among 62,370 Women
2021 · Xiaoliang Wang, Pooja Middha Kapoor, et al. · Research Square · 1
PDF
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
2021 · Juliette Coignard, Michael Lush, et al. · Nature Communications · 40
PDF
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
2021 · NBCS Collaborators, Nichola Johnson, et al. · British Journal of Cancer · 9
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
2020 · Jingjing Liu, Wendy J. C. Prager - van der Smissen, et al. · Scientific Reports · 6
PDF
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
2020 · Pooja Middha Kapoor, Nasim Mavaddat, et al. · JNCI Journal of the National Cancer Institute · 65
PDF
Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
2020 · Helian Feng, Alexander Gusev, et al. · Genetic Epidemiology · 39
PDF
Year
Topic